Therapeutic efficacy of the novel SHP2 degrader SHP2-D26, alone or in combination, against lung cancer is associated with modulation of p70S6K/S6, Bim and Mcl-1
Article in Cancer Gene Therapy (April 2022)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
SLAM family member 8 is involved in oncogenic KIT‐mediated signalling in human mastocytosis
Article in Experimental Dermatology (June 2018)
FGFR inhibitor BGJ398 and HDAC inhibitor OBP-801 synergistically inhibit cell growth and induce apoptosis in bladder cancer cells
Article in Oncology Reports (December 2017)